| Kristen Koszela, | |
|
101 Founders Bay Rd, Murrells Inlet, SC 29576-8089 | |
| (843) 651-8863 | |
| Not Available |
| Full Name | Kristen Koszela |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 101 Founders Bay Rd, Murrells Inlet, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174921779 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 35882 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristen Koszela, 101 Founders Bay Rd, Murrells Inlet, SC 29576-8089 Ph: () - | Kristen Koszela, 101 Founders Bay Rd, Murrells Inlet, SC 29576-8089 Ph: (843) 651-8863 |
News Archive
From 2003 to 2013, the percentage of nonmedical use of prescription opioids decreased among adults in the U.S., while the prevalence of prescription opioid use disorders, frequency of use, and related deaths increased, according to a study in the October 13 issue of JAMA.
The U.N. on Wednesday "presented a plan to make life-saving health supplies more accessible, while a new report found that, despite impressive reductions in maternal and child mortality in the past decade in some countries, millions of women and children still die every year from preventable causes," the U.N. News Centre reports.
A Queen's obstetrics professor has founded one of the first clinics in the world to use pregnancy and the postpartum as a key opportunity in a woman's life to focus on disease prevention.
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV- (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years. INTUNIV, a once-daily formulation of guanfacine, is the first selective alpha-2A adrenergic receptor agonist approved for the treatment of ADHD.
› Verified 9 days ago
Mrs. Carolyn Patricia Sobczyk, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2872 S Highway 17, Murrells Inlet, SC 29576 Phone: 843-357-3985 Fax: 843-357-4216 | |
Dr. Ronald James Pompeii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Founders Bay Rd, Murrells Inlet, SC 29576 Phone: 843-651-8863 Fax: 843-651-8864 | |
Mr. William Robert Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3579 Hwy 17 Business, Murrells Inlet, SC 29576 Phone: 843-651-7979 Fax: 843-651-3319 | |
Dr. Erin Rogers Richardson, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3710 Highway 17 Bypass, Murrells Inlet, SC 29576 Phone: 843-651-8975 | |
Dr. Deena Russell Fournier, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11980 Highway 17 Byp, Murrells Inlet, SC 29576 Phone: 843-357-2000 | |
Tommy Francis Simmons, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 529 Nautilus Dr, Murrells Inlet, SC 29576 Phone: 843-616-4018 Fax: 843-650-1032 | |
Calvin F Muller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2872 S Highway 17, Murrells Inlet, SC 29576 Phone: 843-357-3985 Fax: 843-357-4216 |